批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2020/12/29 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/11/01 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/11/01 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/06/13 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/04/25 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/04/25 |
SUPPL-4(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2013/04/25 |
SUPPL-3(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2012/06/27 |
SUPPL-2(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2011/06/09 |
SUPPL-1(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/06/14 |
ORIG-1(原始申请) |
Approval |
Type 4 - New Combination |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE 剂型/给药途径:CAPSULE;ORAL 规格:0.5MG;0.4MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022460 |
001 |
NDA |
JALYN |
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE |
CAPSULE;ORAL |
0.5MG;0.4MG |
Prescription |
Yes |
Yes |
AB |
2010/06/14
|
WAYLIS THERAP |
202509 |
001 |
ANDA |
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE |
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE |
CAPSULE;ORAL |
0.5MG;0.4MG |
Prescription |
No |
No |
AB |
2014/02/26
|
ENDO OPERATIONS |
207769 |
001 |
ANDA |
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE |
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE |
CAPSULE;ORAL |
0.5MG;0.4MG |
Prescription |
No |
No |
AB |
2018/05/24
|
ZYDUS PHARMS |
213300 |
001 |
ANDA |
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE |
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE |
CAPSULE;ORAL |
0.5MG;0.4MG |
Prescription |
No |
No |
AB |
2024/07/18
|
AUROBINDO PHARMA |